search
for
 About Bioline  All Journals  Testimonials  Membership  News


Journal of Postgraduate Medicine
Medknow Publications and Staff Society of Seth GS Medical College and KEM Hospital, Mumbai, India
ISSN: 0022-3859 EISSN: 0972-2823
Vol. 52, Num. 3, 2006, pp. 163-166

Journal of Postgraduate Medicine, Vol. 52, No. 3, July-September, 2006, pp. 163-166

Original Article

Antibiotic resistance of Salmonella enterica serovar Paratyphi A in India: Emerging and reemerging problem

Department of Bacteriology and Serology, Calcutta School of Tropical Medicine, C. R. Avenue, Kolkata - 700 073
Correspondence Address:Department of Bacteriology and Serology, Calcutta School of Tropical Medicine, C. R. Avenue, Kolkata - 700 073, samtropmed@rediffmail.com

Code Number: jp06055

Abstract

Background: Antibiotic resistance pattern and R-plasmid of Salmonella enterica serovar Paratyphi A isolates from Kolkata, India are not well documented.
Aims: To determine the trend of antibiotic resistance of S. paratyphi A isolates.
Settings and Design:
A retrospective study was carried out using blood culture isolates of S. paratyphi A (1991 to 2005) obtained from patients of enteric fever from Asansol and Kolkata and its suburbs (India).
Materials and Methods:
Antibiotic susceptibility pattern, using seven antibiotics, for the isolates was determined following agar dilution and disk diffusion methods. Transferability of multidrug resistance to ampicillin (Am), chloramphenicol (Chl), cotrimoxazole (Cot) and tetracycline (Tet) among the isolates was determined by in vitro conjugation. The multi-drug resistant (MDR) and antibiotic susceptible S. paratyphi A strains and the trans-conjugants were screened for the presence of plasmid.
Statistical Analysis Used:
The t test was used to compare the difference between mean minimum inhibitory concentration values of ciprofloxacin (Cp) for nalidixic acid (Nx)-resistant and Nalidixic acid (Nx)-susceptible isolates.
Results:
Among 13 outbreak causing isolates in 1991, 9 (69.23%) showed AmChlCotTet-resistance, while 4 (30.77%) Cot-resistance only. During 1992-1994, all 13 isolates were susceptible to Am, Chl, Cot and Tet. During 1995-2005, isolates demonstrated different resistance patterns and emergence of nalidixic acid (Nx)-resistance. A transferable plasmid conferring AmChlCotTet-resistance was detected among MDR isolates. All the isolates were susceptible to ceftriaxone (Ctx) and ciprofloxacin (Cp). Association between Nalidixic acid (Nx)-resistance and reduced susceptibility to ciprofloxacin (Cp) among 59 S. paratyphi A isolates was noticed ( P <0.001).
Conclusion:
Vigilance for R-plasmid and surveillance of antibiotic susceptibility among S. paratyphi A isolates in and around Kolkata, India, are mandatory in order to combat antibiotic resistance of the isolates in this part of the world.

Keywords: Salmonella enterica serovar S. paratyphi A, multidrug resistance, minimum inhibitory concentration, R-plasmid.

The most common Salmonella species that cause enteric fever include Salmonella enterica serovar Typhi and Salmonella enterica serovar S. paratyphi A.[1],[2],[3] Emergence of multidrug resistant (MDR) although there are several Indian reports citing the drug resistance developed by S . Typhi isolates, such data regarding S. paratyphi A is scanty.[4],[5],[6] Therefore, the present study was undertaken to assess the antibiotic resistance of S. paratyphi A isolates obtained during 1991 to 2005.

Materials and Methods

Ninety-five S. paratyphi A isolates from blood samples of patients with enteric fever undergoing treatment at Calcutta School of Tropical Medicine, Kolkata (India) during 1991 to 2005 were used in the present study. The patients were from different places of the West Bengal state (India): Asansol and Kolkata and its suburbs. The control strain used in the study was Escherichia coli ATCC 25922, while E. coli V517 strain was used as the molecular marker for plasmid.

The isolates, which were stored and maintained in cystine tryptone agar stabs with or without antibiotics, were tested for susceptibility to ampicillin (Am), chloramphenicol (Chl), co-trimoxazole (Cot), tetracycline (Tet), nalidixic acid (Nx), ciprofloxacin (Cp) and ceftriaxone (Ctx) by disc diffusion method using the guidelines provided by the National Committee for Clinical Laboratory Standards (NCCLS).[7] The antibiotic contents (mg/disc) of the discs (Hi-Media, Mumbai, India) were Am (25), Chl (30), Cot (25), Tet (10), Nx (30), Cp (5) and Ctx(30) and the media used were Mueller-Hinton agar and Mueller-Hinton broth (Hi-Media, Mumbai, India).

For all the S. paratyphi A isolates, minimum inhibitory concentration values (MICs) of the antibiotics: Am, Chl, Nx and Ctx (Sigma Chemicals, St. Louis, USA) and Tet, Cp and Cot (sulphamethoxazole + trimethoprim) from Hi-Media Laboratory Limited, Mumbai, India, were determined by agar dilution method according to the NCCLS criteria,[8] using Mueller-Hinton agar.

Transferability of antibiotic resistance was determined by in vitro conjugation experiments performed according to the protocol of Jevanand et al ,[9] with slight modification,[10] using drug resistant S. paratyphi A isolates as donors and Escherichia coli C 600 (NxR, F-) as recipient.

MDR S. paratyphi A, their transconjugants and the S. paratyphi A strains showing susceptibility to antibiotics (Am, Chl, Cot and Tet) were selected for plasmid DNA isolation by alkaline lysis method of Birnboim and Doly[11] with some modifications. Briefly, from 10 ml of bacterial culture (in nutrient broth, Hi-Media, India) plasmid DNAs were isolated using 0.48 ml, 1 ml and 0.8 ml of solution I, II and III, respectively. After the addition of solution III, the lysate was kept in ice for 30 minutes and centrifuged for 15 minutes. Phenol-chloroform (1:1) was followed with the clear supernatent, plasmid DNA was precipitated with 0.8 volume of chilled isopropyl alcohol and DNA pellet was dissolved in 100 ml of TE buffer. Agarose gel electrophoresis of the isolated plasmid DNAs was carried out in tris-borate buffer system,[12] using 0.8% agarose, for 4 h at 50v. The gel was stained with ethidium bromide and results were documented in gel-doc system. Electrophoretic separation of plasmid by molecular weight and subsequent size estimations were accomplished using reference strain of E. coli V517.

The association between Nx-resistance and decreased Cp susceptibility was determined using the t test wherein difference between mean MIC values of Cp and Nx for Nx-resistant S. paratyphi A isolates was compared. The 95% confidence interval of the mean MICs of Nx and Cp for Nx-resistant isolates was calculated.

Results

The antibiotic resistance patterns of S. paratyphi A isolates are shown in [Figure - 1]. In 1991, two types of antibiotic resistance patterns were noticed: "AmChlCotTet" in 9 (69.23%) and "Cot" in 4 (30.77%) isolates. All the isolates of 1992-1994 and 9 (75%) and one (11.11%), respectively of the year 1995 and 1996 were susceptible to antibiotics studied. The rest of the isolates of 1995 (n=3, 25%) and 1996 (n=8, 88.89%) and all isolates of the year 1997 (n=10) were Nx-resistant. Between the years 1998 and 2001, including Nx-resistance, different patterns of resistance were found among the isolates of S. paratyphi A: AmChlCotTetNx in 1998 (n=3, 30%), in 2000 (n=2, 25%) and in 2001 (n=1, 16.67%); ChlCotTetNx in 2000 (n=2, 25%); and CotNx in 1998 (n=1, 10%), in 1999 (n=1, 33.33%), in 2000 (n=1, 12.5%) and in 2001 (n=1, 33.33%). Among 11 S. paratyphi A isolates, which were obtained during 2002-2005, two (18.2%) showed "NxCot" resistance pattern, while the remaining 9 (81.8%) were resistant to Nx, but susceptible to four antibiotics namely Am, Chl, Cot and Tet. The MDR isolates showed high level of MIC to Am (500-6000 μg/ml), Chl (500-3000 μg/ml), Cot (125-600 μg/ml) and Tet (75-600 μg/ml).

The MIC values of Cp for 95 S. paratyphi A isolates (1991-2005) are shown in [Figure - 2]. All the S. paratyphi A isolates (n=26) obtained during 1991-1994, 9 (75%) isolates in 1995 and one (11.11%) in 1996 showed Cp MICs 0.005-0.05 μg/ml. Remaining 3 (25%) and 8 (88.89%) isolates obtained during 1995 and 1996, respectively and all 48 (100%) isolates during 1991-2005 had Cp MICs 0.5-1.25 μg/ml.

The correlation between the MIC values of Cp and that of Nx is shown in [Figure - 3]. Among 95 S. paratyphi A isolates, 36 (37.9 %) isolates for which Cp MICs were ≤ 0.05 μg/ml were susceptible to Nx (MICs ≤ 16 μg/ml) and remaining 59 (62.1 %) isolates for which Cp MICs were 0.1-1.25 μg/ml were Nx-resistant (MICs 32-256 μg/ml). [Table - 1] represents the association between Nx-resistance and reduced susceptibility to Cp among 59 S. paratyphi A isolates ( P values 0.001). With 95% confidence, the mean Nx MIC ranged from 86.14 to 130.80 μg/ml and the mean Cp MIC from 0.58 to 0.8 mg/ml. All the isolates showed susceptibility to Ctx by both disc diffusion and agar dilution methods. The MICs of the agent was in between 0.005-0.25 μg/ml.

The MDR isolates having resistance patterns of AmChlCotTetNx and AmChlCotTet transferred the resistance property for Am, Chl, Cot and Tet to E. coli C600 recipients; Nx-resistance was not transferred. MDR S. paratyphi A strains and their corresponding transconjugants contained a plasmid of the same molecular size (approximately 55 Kb) conferring resistance to Am, Chl, Cot and Tet. The isolates, which were susceptible to these four agents, were plasmidless.

Discussion

Emergence of MDR S. paratyphi A isolates causing enteric fever has been reported from different parts of the world including India.[4],[5],[13],[14] In the present study, both susceptible and resistant isolates were obtained and the resistant isolates showed flip-flop patterns of antibiotic resistance with high MICs of Am, Chl, Cot and Tet. All the isolates involved in the enteric fever outbreak during 1991 were drug resistant. Enteric fever out- break caused by drug resistant S. paratyphi A has been reported earlier from India.[15] Emergence of such drug resistant S. paratyphi A isolates of high MIC values might be due to indiscriminate use of antibiotics in enteric fever.

Drug resistance in S. paratyphi A isolates was reported to be plasmid mediated. Rangnekar et al[4] reported R-plasmid encoding resistance for Am, Chl, sulfonamides (Su) and Tet in 3 strains of S. paratyphi A. The present investigation also provides the evidence of involvement of a transferable R-plasmid encoding AmChlCotTet-resistance, in S. paratyphi A isolates. Results of in vitro transfer studies, presence of plasmid of same molecular size in the donor S. paratyphi A strains and in their corresponding transconjugants and absence of plasmid in the antibiotic sensitive S. paratyphi A isolates supports this view. Thus, vigilance for R-plasmids in Salmonella isolates, including other Enterobacteriaceae is essential.

Since 1990, Cp has formed the mainstay of anti-microbial therapy for patients with MDR enteric fever in India. This practice relieved the selection pressure on antibiotics such as Am, Chl and Cot and led to the re-emergence of S. paratyphi A isolates susceptible to these antibiotics. This is evident in our study from the fact that all S. paratyphi A isolates obtained during 1992-1994 were susceptible. However, with the rampant use of Cp, the price was paid in the form of emergence of S. paratyphi A isolates with high MICs of Cp (≥ 0.1 μg/ml), as recorded in our study. The present study showed a gradual increase in MICs of Cp, from 0.005 to 1.25 μg/ml, among the isolates pointing towards the emergence of Cp-resistant isolates in recent years.[16] But, such resistance of S. paratyphi A isolates to Cp was not detected by the NCCLS guidelines, which use the MICs of ≤ 1 μg/ml and ≥ 4 μg/ml as respective breakpoints for Cp susceptibility and resistance.[8] In the present study, association of Nx resistance (≥32 μg/ml) with decreased Cp susceptibility (≥ 0.1 μg/ml) was noticed among the isolates. Therefore, Nx resistance can be used as a tool to detect Cp resistance of Salmonella isolates.[15] Emergence of S. paratyphi A causing treatment failure due to high Cp MICs has been reported earlier.[5] In this situation, there seems to be room for considering using the conventional antibiotics (Am, Chl and Cot) for the treatment of enteric fever. The fact that most of the S. paratyphi A isolates of 2000 and 2001 to 2005 in the present investigation were susceptible to these agents supports such a strategy. However, for MDR S. paratyphi A infection, Ctx therapy was found effective.

Considering the small number of samples studied, the resistance pattern obtained in our study may not represent the true picture of S. paratyphi A resistance in the community. The fact that most of the patients suspected to have enteric fever in our country do not undergo blood culture and antibiogram studies, may be responsible for the small number of isolates obtained. Nevertheless, the study underlines the importance of testing anti-microbial susceptibility of S. paratyphi A isolates from different parts of the West Bengal state (India), in order to prepare effective treatment regimens to combat antibiotic resistance in different regions of the state.

Acknowledgements

Authors are thankful to Dr. P. Roy, Lecturer, Department of Microbiology and Dr. P. K. Saha, Chairman, Department of Botany, Bose Institute, Kolkata for extending help and guidance regarding plasmid DNA isolation and gel documentation. We also acknowledge the help of Dr. B. L. Sarkar, Assistant Director, NICED, Kolkata, for providing the E. coli V517 strain.

References

1.Bavdekar SB. Antimicrobial therapy of multidrug resistant typhoid fever in children: Pediatricians' opinion. J Postgrad Med 1996;42:65-7.  Back to cited text no. 1    
2.Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006;14:1-6.   Back to cited text no. 2    
3.Mendiratta DK, Deotale V, Thamke D, Narang R, Narang P. Enteric Fever due to Salmonella enterica serotype Paratyphi A - An Emerging Problem. Indian J Med Microbiol 2004;22:196.  Back to cited text no. 3    
4.Rangnekar VM, Banker DD, Jhala HI. Antimicrobial resistance and R-plasmids of Salmonella paratyphi A isolated at Bombay. Indian J Med Res 1983;77:5-9.  Back to cited text no. 4  [PUBMED]  
5.Chandel DS, Chaudhry R, Dhawan B, Pandey A, Dey AB. Drug-resistant Salmonella enterica Paratyphi A in India. Emerg Infect Dis 2000;6:420-1.  Back to cited text no. 5  [PUBMED]  [FULLTEXT]
6.Tankhiwale SS, Agrawal G, Jalgaonkar SV. An unusually high occurrence of Salmonella enterica serotype Paratyphi A in patients with enteric fever. Indian J Med Res 2003;117:10-2.  Back to cited text no. 6  [PUBMED]  
7.National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests: approved standards. 6th ed. The Committee: Wayne (PA); 1997.   Back to cited text no. 7    
8.National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically: Approved standards. 4th ed. The Committee: Wayne (PA); 1997.  Back to cited text no. 8    
9.Jevanand HR, Ragavan PU, Gunapathi RS. Study of R-factors among multidrug resistant Salmonella typhi . Indian J Med Microbiol 1997;15:37-9.  Back to cited text no. 9    
10.Mandal S, Deb Mandal M, Pal NK. R-factor in Salmonella enterica serovar Typhi: Transfer to and acquisition from Escherichia coli. Jpn J Infect Dis 2003;56:65-7.  Back to cited text no. 10    
11.Birnboim HC, Doly J. A rapid alkaline procedure for screening recombinant plasmid DNA. Nucleic Acid Res 1979;7:1513-23.  Back to cited text no. 11  [PUBMED]  [FULLTEXT]
12.Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory: New York; 1982.  Back to cited text no. 12    
13.Ali MA, Qureshi AH, Rafi S, Mirza SH. Changing frequencies and current status of Multiple-Drug Resistant Typhoidal Salmonellae in year 2001-2003 at Rawalpindi. Infect Dis J 2005;14:3-6.  Back to cited text no. 13    
14.Hirose K, Tamura K, Sagara H, Watanabe H. Antibiotic susceptibilities of Salmonella enterica serovar Typhi and S. enterica serovar Paratyphi A isolated from patients in Japan. Antimicrob Agents Chemother 2001;45:956-8.  Back to cited text no. 14  [PUBMED]  [FULLTEXT]
15.Mahanta J. Drug sensitivity of Salmonella paratyphi A isolated from a suspected out break of enteric fever in Duliajan. J Indian Med Assoc 1994;92:49-50.  Back to cited text no. 15  [PUBMED]  
16.Aarestrup FM, Wiuff C, Mψlbak K, Threlfall EJ. Is it time to change fluoroquinolone breakpoints for Salmonella spp? Antimicrob Agents Chemother 2003;47:827-9.  Back to cited text no. 16    

Copyright 2006 - Journal of Postgraduate Medicine


The following images related to this document are available:

Photo images

[jp06055f1.jpg] [jp06055t1.jpg] [jp06055f3.jpg] [jp06055f2.jpg]
Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil